title: [CTL precursor-oriented peptide vaccine therapy for malignant glioma].
authors.affiliation: Department of Neurosurgery, Brain Research Institue, Niigata University.
authors.forename: Naoki
authors.initials: N
authors.lastname: Yajima
authors.forename: Ryuya
authors.initials: R
authors.lastname: Yamanaka
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Tanaka
authors.forename: Minoru
authors.initials: M
authors.lastname: Shigemori
authors.forename: Takashi
authors.initials: T
authors.lastname: Mine
authors.forename: Kyougo
authors.initials: K
authors.lastname: Itoh
mesh_terms: D001932:Brain Neoplasms / Q000628:therapy*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D018984:Epitopes, T-Lymphocyte; D005910:Glioma / Q000628:therapy*; D006680:HLA Antigens; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008562:Membrane Glycoproteins / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D022223:Vaccines, Subunit / Q000627:therapeutic use
chemical_list: D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D006680:HLA Antigens; D008562:Membrane Glycoproteins; D022223:Vaccines, Subunit; C053387:endoplasmin